Page last updated: 2024-08-23

nicorandil and 2019 Novel Coronavirus Disease

nicorandil has been researched along with 2019 Novel Coronavirus Disease in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	4 (100.00)	2.80

Authors

Authors	Studies
Ashour, H; Elmorsy, S; Elsayed, MH; Harb, IA	1
Jabeen, B; Mir, TH; Zahoor, A; Zargar, PA	1
Bhandari, S; Dadhwal, DS; Dogra, V; Gupta, S; Raina, S; Sharma, A; Sharma, C; Singh, B; Sood, V	1
Lionetti, V; Razeghian-Jahromi, I; Safari, A	1

Reviews

1 review(s) available for nicorandil and 2019 Novel Coronavirus Disease

Article	Year
Hypothesis: The potential therapeutic role of nicorandil in COVID-19. Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:11 Topics: Anti-Inflammatory Agents; Anticoagulants; Antioxidants; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Fibrosis; Humans; Nicorandil; Pandemics; Pneumonia, Viral; Vasodilator Agents	2020

Trials

1 trial(s) available for nicorandil and 2019 Novel Coronavirus Disease

Article	Year
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial. Trials, 2021, Jul-15, Volume: 22, Issue:1 Topics: Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome	2021

Article

Year

A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.

Trials, 2021, Jul-15, Volume: 22, Issue:1

Topics: Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome

2021

Other Studies

2 other study(ies) available for nicorandil and 2019 Novel Coronavirus Disease

Article	Year
Nicorandil a magic bullet or a double edged sword in critically ill COVID-19 patients? Clinical and experimental pharmacology & physiology, 2021, Volume: 48, Issue:6 Topics: COVID-19; Critical Illness; Humans; Nicorandil; SARS-CoV-2; Vasodilator Agents	2021
Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction. Stem cell research & therapy, 2021, 07-15, Volume: 12, Issue:1 Topics: COVID-19; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Multiple Organ Failure; Nicorandil; SARS-CoV-2	2021